Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thrombin].

M Camici1, A Sagripanti, R Di Mitri

  • 1Dipartimento di Medicina Interna, Università degli Studi, Pisa.

Minerva Medica
|November 21, 2000
PubMed
Summary
This summary is machine-generated.

This study reviews how thrombin

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Comparative efficacy of different bowel preparations for colonoscopy: A network meta-analysis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2024
Same author

Ocular involvement in monkeypox: Description of an unusual presentation during the current outbreak.

The Journal of infection·2022
Same author

Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial.

European review for medical and pharmacological sciences·2020
Same author

Colorectal cancer in patients with type 2 diabetes mellitus: a single-center experience.

Journal of biological regulators and homeostatic agents·2017
Same author

A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same journal

How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

Minerva medica·2026
Same journal

Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

Minerva medica·2026
Same journal

Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

Minerva medica·2026
Same journal

Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

Minerva medica·2026
Same journal

Iron deficiency and risk of acute kidney injury after TAVI: a machine learning analysis.

Minerva medica·2026
Same journal

Therapeutic adherence and health literacy: a perfect match in dyslipidemic patients.

Minerva medica·2026
See all related articles

Area of Science:

  • Biochemistry
  • Pharmacology

Background:

  • Thrombin is a key enzyme in blood coagulation.
  • Its structure dictates its biological activity and interactions.

Purpose of the Study:

  • To survey current knowledge on thrombin's structure-activity relationships.
  • To evaluate recent research on inhibiting thrombin function.

Main Methods:

  • Literature review of biochemical and pharmacological studies.
  • Analysis of structure-activity data for thrombin inhibitors.

Main Results:

  • Detailed understanding of how thrombin's structural features influence its enzymatic activity.
  • Identification of promising pharmacological strategies for thrombin inhibition.

Conclusions:

  • Structure-activity relationships are crucial for developing targeted thrombin inhibitors.
  • Pharmacological blockade of thrombin holds therapeutic potential.